FIELD: medicine.
SUBSTANCE: invention refers to a compound presented by formula (1), to its salt or hydrate where in formula R1 represents a methylene group, R2 represents a phenyl group which can contain a substitute(s), or a heterocyclic group which can contain a substitute(s), the cycle A represents a 6- or 7-members cycle (where cycle-making atoms of the cycle A different from a sulfur atom in position 6 are carbon atoms), and R3 represents a hydrogen atom, or 1-3 equal or different substitutes used to substitute the cycle A where the possible substitutes are specified in clause 1 of the patent claim. Also, the invention refers to a pharmaceutical composition exhibiting an anticancer activity, on the basis of the compound presented by formula (1).
EFFECT: there are produced new compounds and pharmaceutical composition on their basis which can find application in medicine for cancer treatment.
Title | Year | Author | Number |
---|---|---|---|
TRICYCLIC PYRAZOLOPYRIMIDINE DERIVATIVE | 2010 |
|
RU2520966C2 |
NEW CYCLIC DINUCLEOTIDE DERIVATIVE AND ITS ANTIBODY-DRUG CONJUGATE | 2019 |
|
RU2809547C2 |
VASOPRESSIN V RECEPTOR ANTAGONISTS | 2005 |
|
RU2370497C2 |
CONDENSED AMINOHYDROTHIAZINE DERIVATIVE | 2009 |
|
RU2476431C2 |
PIRAZOLOQINOLINE DERIVATIVE | 2012 |
|
RU2605096C2 |
BENZOXEPIN PI3 INHIBITORS AND METHODS FOR USING THEM | 2010 |
|
RU2557658C2 |
SUBSTITUTED CHROMANS | 2015 |
|
RU2718060C2 |
SUBSTITUTED TRICYCLIC COMPOUNDS AND METHOD OF APPLICATION | 2016 |
|
RU2744766C2 |
THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5HT RECEPTOR LIGANDS AND USE THEREOF | 2007 |
|
RU2434872C2 |
PYRROLOPYRIDINONE DERIVATIVES AS TTX-S BLOCKERS | 2013 |
|
RU2646754C2 |
Authors
Dates
2011-06-10—Published
2007-09-14—Filed